Sign up to save your podcasts
Or
Share Unintentional Bias of Breast Cancer Randomized Clinical Trial Interpretations Through Discontinuation Imbalance
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Unintentional Bias of Breast Cancer Randomized Clinical Trial Interpretations Through Discontinuation Imbalance
Some of the big randomized clinical trials could lead to unintentional bias because of an imbalance of assigned treatment discontinuations between experimental and control arms, according to ASCO poster author Faris Tamimi, MD, at the University Health Network Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre. OncTimesTalk correspondent Peter Goodwin talked with Tamimi at the 2023 ASCO Annual Meeting.
View all episodes
By 
4.3
33 ratings
Some of the big randomized clinical trials could lead to unintentional bias because of an imbalance of assigned treatment discontinuations between experimental and control arms, according to ASCO poster author Faris Tamimi, MD, at the University Health Network Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre. OncTimesTalk correspondent Peter Goodwin talked with Tamimi at the 2023 ASCO Annual Meeting.